Sharing common principles: Blending the primary health care and harm reduction paradigms to meet common health goals in HIV/AIDS prevention

Australian Journal of Primary Health

Volumn 12, Issue 3, 2006, Pages 34-43

  Pankonin, Christopher A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE   (Australia)

Author keywords

Harm reduction; HIV AIDS; Primary Health Care; Social determinants of health

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL EFFECTIVENESS; COMMUNITY CARE; COUNSELING; DEVELOPING COUNTRY; DRUG COST; EMPLOYMENT; HEALTH CARE DELIVERY; HIGH RISK BEHAVIOR; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MEDICAL SERVICE; MENTAL HEALTH; MORBIDITY; PATIENT REFERRAL; PRIMARY HEALTH CARE; PROPHYLAXIS; REVIEW; SOCIAL WORK; SYRINGE;

EID: 33845626929     PISSN: 14487527     EISSN: None     Source Type: Journal    
DOI: 10.1071/PY06043     Document Type: Review

References (71)

1. Al-Ahmadi, H., & Roland, M. (2005). Quality of primary health care in Saudi Arabia: a comprehensive review. International Journal for Quality in Health Care, 17(4), 331-346.
2. Bamisaiye, A., Olukoya, A., Ekunwe, E. O., & Abosede, O. A. (1989). A village health worker programme in Nigeria. World Health Forum, 10, 386-392.
3. Barros, F. C., Forsberg, B. G., Victora, C. G., Maranhao, A. G., Stegeman, M., Gonzalez-Richmond, A., Martins, R. M., Neumann, Z. A., McAuliffe, J., & Branco Junior, J. A. (1994). Quality assurance of a diarrhoea control programme in northeastern Brazil. Scandinavian Journal of Social Medicine, 22(1), 35-40.
4. Beyers, J. M., Evans-Whipp, T., Mathers, M., Toumbourou, J. W., & Catalano, R. F. (2005). A cross-national comparison of school drug policies in Washington State, United States, and Victoria, Australia. The Journal of School Health, 75, 134-140.
5. Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14, 605-611.
6. Carr, S., Goldberg, D. J., Elliott, L., Green, S., Mackie, C., & Gruer, L. (1996). A primary health care service for Glasgow street sex workers: 6-years experience of the 'Drop-in Centre', 1989-1994. AIDS Care, 8(4), 489-497.
7. Centers for Disease Control and Prevention. (1999). Increases in unsafe sex and rectal gonorrhea among men who have sex with men - San Francisco, California, 1994-1997. Morbidity and Mortality Weekly Report, 48, 45-48.
8. Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. (2004). Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18, 887-895.
9. Cohen, D. A., Wu, S. Y., & Farley, T. (2004). Comparing the cost-effectiveness of HIV prevention interventions. Journal of Acquired Immune Deficiency Syndromes, 37, 1404.
10. Commonwealth Department of Health and Ageing. (2002). Return on investment in needle and syringe programs in Australia. Canberra. Commonwealth of Australia. Retrieved 15 February 2006 from http://www.health.gov.au/pubhlth/ publicat/hac.htm
11. Costigan, G., Crofts, N., & Reid, G. (2003). Manual for Reducing Drug Related Harm In Asia. Melbourne: The Centre for Harm Reduction, Burnet Institute.
12. Cufino Svitone, K., Garfield, R., Vasconcelos, M. I., & Araujo Craveiro, V. (2000). Primary health care lessons from the northeast of Brazil: the Agentes de Saude Program. Pan American Journal of Public Health, 7(5), 293-302.
13. Dehne, K. L., Pokrovskiy, V., Kohyshcha, Y., & Schwartlander, B. (2000). Update on the epidemics of HIV and other sexually transmitted infections in the newly independent states of the former Soviet Union. AIDS, 14, S75-S84.
14. Des Jarlais, D., Perlis, T., Friedman, S.R., Deren, S., Chapman, T., Sotheran, J. L. et al. (1998). Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88, 1801-1806.
15. Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T. et al. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348, 987-991.
16. Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., Wenston, J., Marmor, M., Yancovitz, S. K. et al. (1994). Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. Journal of the American Medical Association, 271, 121-127.
17. Des Jarlais, D. C., Friedman, S. R., & Hopkins, W. (1985). Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Annals of Internal Medicine, 103, 755-759.
18. Donoghoe, M. C., Stimson, G. V., Dolan, K., & Alldritt, L. (1989). Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland. AIDS, 3, 267-272.
19. Ehiri, J. E., Oyo-Ita, A. E., Anyanwu, E. C., Meremikwu, M. M., & Ikpeme, M. B. (2005). Quality of child health services in primary health care facilities in south-east Nigeria. Child: Care, Health & Development, 31(2), 181-191.
20. Ezard, N. (2001). Public health, human rights and the harm reduction paradigm: from risk reduction to vulnerability reduction. International Journal of Drug Policy, 12, 207-219.
21. Farmer, P., Léandre, F., Mukherjee, J. S., Claude, M. S., Nevil, P., Smith-Fawxi, M. C. et al. (2001). Community-based approaches to HIV treatment in resource-poor settings. Lancet, 358, 404-409.
22. Gayle, H., & Lange, J. M. A. (2004). Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention. The Lancet, 364, 6-8.
23. Gibson, D. R., Flynn, N. M., & Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 15, 1329-1341.
24. Glendinning, C., Rummery, K., & Clarke, R. (1998). From collaboration to commissioning: developing relationships between primary health and social services. British Medical Journal, 317, 122-125.
25. Gold, M., Gafni, A., Nelligan, P., & Millson, P. (1997). Needle exchange programs: an economic evaluation of a local experience. Canadian Medical Association; Association médicale canadienne, 157, 255-262.
26. Goodman, C. A., Coleman, P. G., & Mills, A. J. (1999). Cost-effectiveness of malaria control in sub-Saharan Africa. The Lancet. 354, 378-385.
27. Hathaway, A. D. (2002). From harm reduction to human rights: bringing liberalism back into drug reform debates. Drug and Alcohol Review, 21, 397-404.
28. Hill, P. S. (2002). The rhetoric of sector-wide approaches for health development. Social Science and Medicine, 54, 1725-1737.
29. Hill, A. G., MacLeod, W. B., Joof, D., Gomez, P., & Walraven, G. (2000). Decline of mortality in children in rural Gambia: the influence of village-level primary health care. Tropical Medicine & International Health, 5(2), 107-118.
30. Hogan, D. R. & Salomon, J. A. (2005). Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings. Bulletin of the World Health Organization, 83, 135-143.
31. Holmberg, S. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642-654.
32. Hurley, S. F., Jolley, D. J., & Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797-1800.
33. International Harm Reduction Association. What is Harm Reduction? Discussion Papers International Harm Reduction Association. Retrieved 24 June 2005 from http://www.ihra.net/index.php?option=articles&Itemid=3&topid= 0&Itemid=3#.
34. Kawichai, S., Beyrer, C., Khamboonruang, C., Celentano, D.D., Natpratan, C., Rungruengthanakit, K., & Nelson, K.E. (2004). HIV incidence and risk behaviours after voluntary HIV counseling and testing (VCT) among adults aged 19-35 years living in peri-urban communities around Chiang Mai city in northern Thailand, 1999. AIDS Care, 16, 21-35.
35. Kelley, M. S., Murphy, S., & Lune, H. (2001). A cultural impact of needle exchange: The role of safer-injection mentors. Contemporary Drug Problems, 28, 485-506.
36. Kumaranayake, L., Vickerman, P., Walker, D., Samoshkin, S., Romantzov, V., Emelyanova, Z., Zviagin, V., & Watts, C. (2004). The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction, 99, 1565-1576.
37. Laurent, C., Diakhate, N., Gueye, N. F., Toure, M. A., Sow, P. S., Faye, M. A., Gueye, M., Laniece, I., Toure Kane, C., Liegeois, E., Vergne, L., Mboup, S., Badiane, S., Ndoye, I., & Delaporte, E. (2002). The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS, 16, 1303-1370.
38. Lenton, S., & Single, E. (1998). The definition of harm reduction. Drug and Alcohol Review, 17, 213-220.
39. Lurie, P., Jones, T. S., & Foley, J. (1998). A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Supp. 1), S45-S51.
40. MacDonald, M., Law, M., Kaldor, J., Hales, J., & Dore, G.J. (2003). Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy, 14, 353-357.
41. MacDonald, J. J. (1992). Primary Health Care: Medicine in its place, London: Earthscan.
42. Mercer, A., Khan, M. H., Daulatuzzaman, M., & Reid, J. (2004). Effectiveness of an NGO primary health care programme in rural Bangladesh: evidence from the management information system. Health Policy & Planning, 19(4), 187-198.
43. Musich, S. A., Adams, L., & Edington, D.W. (2000). Effectiveness of health promotion programs in moderating medical costs in the US. Health Promotion International, 15, 5-15.
44. Newcombe, R. (1992). The reduction of drug related harm: a conceptual framework for theory, practice and research. In P. O'Hare, R. Newcombe, A. Mathews E. Buning, E. Drucker (Eds.). The reduction of drug related harm. London: Routledge.
45. Poland, B. D., Tupker, E., & Breland, K. (2002). Involving street youth in peer harm reduction education. Canadian Journal of Public Health, 93, 344-348.
46. Remis, R. S., Bruneau, J., & Hankins, C.A. (1998). Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18 (Suppl 1:8), 57-59.
47. Riley, D. & O'Hare, P. (2000). Harm Reduction: History, Definition, and Practice. In J. Inciardi, L. Harrison (Eds.). Harm Reduction: National and International Perspectives. London: Sage Publications.
48. Robles, R. R., Colon, H.M., Matos, T.D., Finlinson, H.A., Munoz, A., Marrero, C.A., Garcia, M., & Reyes, J.C. (1998). Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico. Health Policy, 45, 209-220.
49. Rubardt, M., Chikoko, A., Glik, D., Jere, S., Nwanyanwu, O., Zhang, W., Nkhoma, W., & Ziba, C. (1999). Implementing a malaria curtains project in rural Malawi. Health Policy and Planning, 14, 331-321.
50. Rummery, K. & Coleman, A. (2003). Primary health and social care services in the UK: progress towards partnership? Social Science and Medicine, 56(8), 1773-1782.
51. Saowakontha, S., Pongpaew, P., Vudhivai, N., Tungtrongchitr, R., Sanchaisuriya, P., Mahaweerawat, U., Laohasiriwong, W., Intarakhao, C., Leelapanmetha, P., Chaisiri, K., Vatanasapt, V., Merkle, A., & Schelp, F.P. (2000). Promotion of the health of rural women towards safe motherhood-an intervention project in northeast Thailand. Southeast Asian Journal of Tropical Medicine & Public Health, 31 (Suppl 2), 5-21.
52. Sartorelli, D. S., Sciarra, E.C., Franco, L.J., & Cardoso, M.A. (2005). Beneficial effects of short-term nutritional counselling at the primary health-care level among Brazilian adults. Public Health Nutrition, 8(7), 820-825.
53. Schoenbaum, E. E., Hartel, D. M., & Gourevitch, M. N. (1996). Needle exchange use among a cohort of injecting drug users. AIDS, 10, 1729-1734.
54. Selwyn, P., Feiner, C., Cox, C., Lipshutz, C., & Cohen, R. (1987). Knowledge about AIDS and high-risk behavior among intravenous drug abusers in New York City. AJDS, 1, 247-254.
55. Semmaille, P., Dubois, S., & Gennotte, A.F. (2005). Global HIV care in general/family practice. Revue Medicale de Bruxelles, 26(4), S367-377.
56. Shelton, J.D., Halperin, D.T., Nantulya, V., Potts, M., Gayle, H.D., & Holmes, K.K. (2004). Partner reduction is crucial for balanced "ABC" approach to HIV prevention. British Medical Journal, 328, 891-894.
57. Silwer, L., Johansson, E., & Lundborg, C.S. (2002). Drug prescribing in public primary care centres: results from prescription studies 1988-1997 in the county of Halland, Sweden. Scandinavian Journal of Primary Health Care, 20, 236-241.
58. Stimson, G.V. (1995). AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Social Science and Medicine, 41, 699-716.
59. Strang, J. (1993). Drug use and harm reduction: responding to the challenge. In: N. Heather, A. Wodak, E. Nadelmann, P. O'Hare, (Eds.). Psychoactive drugs and harm reduction: from faith to science. London, Whurr Publishers, 3-20.
60. Strathdee, S.A., Patrick, D.M., Currie, S.L., Cornelisse, P.G.A., Rekart, M.L., Montane, J.S.G., Schechter, M.T., & O'Shaughnessy, M.V. (1997). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 11, F59-F65.
61. Sule, S. S. (2003). Childhood morbidity and treatment pattern at the multipurpose health centre, Ilesa, Nigeria. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria, 12(3), 145-149.
62. Tawil, O., Verster, A., & O'Reilly, K. (1995). Enabling approaches for HIV/AIDS prevention: can we modify the environment and minimize the risk? Journal of Acquired Immunodeficiency Syndromes, 9, 1299-1306.
63. Tran, T. T., Nguyen, T. N., Le, T., Truong, C. H., Mogensen, K., & Andersen, E. (1998). Establishment of drug chests in commune health stations in Vietnam, Bamako Initiative. Southeast Asian Journal of Tropical Medicine & Public Health, 29(3), 628-635.
64. van Ameijden, E. J. C. & Coutinho, R. A. (2001). Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health, 55, 356-363.
65. van Ameijden, E. J. C. & Coutinho, R. A. (1998). Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS, 12(6), 625-633.
66. von Massow, F., Korte, R., Cheka, C., Kuper, M., Tata, H., & Schmidt-Ehry, B. (1998). Financially independent primary health care drug supply system in Cameroun. Tropical Medicine & International Health, 3(10), 788-801.
67. Walton, D. A., Farmer, P. E., Lambert, W., Leandre, F., Koenig, S. P., & Mukherjee, J. S. (2004). Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. Journal of Public Health Policy, 25(2), 137-158.
68. Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., Nalugoda, F., Wabwire-Mangen, F., Meehan, M. P., & Quinn, T. C. (2005). Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. The Journal of Infectious Diseases, 191, 1403-1409.
69. Winichagoon, P. (2002). Prevention and control of anemia: Thailand experiences. Journal of Nutrition, 132(4 Suppl), 862S-866S.
70. World Health Organization. (1978). Declaration of Alma-Ata. International Conference on Primary Health Care, Alma-Ata, USSR, 6-12 September 1978.
71. World Health Organization. (2004). Chronic HIV care with ARV therapy: integrated management of adolescent and adult illness: interim guidelines for first-level facility health workers. Geneva: World Health Organization.